September’s Hardman Monthly features an article from guest contributor, Tim Ward. Tim is the Chief Executive of the Quoted Companies Alliance (QCA), an organisation that champions the interests of small to mid-size quoted companies.
03 Sep 2018
The Monthly September 2018
Time Finance plc (TIME:LON), 39.5 | Advanced Oncotherapy Plc (AVO:LON), 1.9 | Allergy Therapeutics plc (AGY:LON), 3.0 | Alliance Pharma plc (APH:LON), 39.6 | Arbuthnot Banking Group PLC (ARBB:LON), 1,080 | Avacta Group PLC (AVCT:LON), 49.8 | Chamberlin plc (CMH:LON), 1.6 | Evgen Pharma Plc (EVG:LON), 0.9 | Genedrive Plc (GDR:LON), 3.4 | Koovs (KOOV:LON), 0 | Murgitroyd Group (MUR:LON), 0 | Oxford BioMedica plc (OXB:LON), 201 | Primary Health Properties PLC (PHP:LON), 94.0 | R.E.A. Holdings plc (RE:LON), 66.0 | Redx Pharma Plc (REDX:LON), 18.5 | Scancell Holdings Plc (SCLP:LON), 10.2 | Surface Transforms PLC (SCE:LON), 9.2 | 600 Group PLC (SIXH:LON), 2.6 | Tissue Regenix Group plc (TRX:LON), 62.5 | Titon Holdings Plc (TON:LON), 77.5 | Warpaint London PLC (W7L:LON), 412 | ValiRx PLC (VAL:LON), 3.6
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
The Monthly September 2018
Time Finance plc (TIME:LON), 39.5 | Advanced Oncotherapy Plc (AVO:LON), 1.9 | Allergy Therapeutics plc (AGY:LON), 3.0 | Alliance Pharma plc (APH:LON), 39.6 | Arbuthnot Banking Group PLC (ARBB:LON), 1,080 | Avacta Group PLC (AVCT:LON), 49.8 | Chamberlin plc (CMH:LON), 1.6 | Evgen Pharma Plc (EVG:LON), 0.9 | Genedrive Plc (GDR:LON), 3.4 | Koovs (KOOV:LON), 0 | Murgitroyd Group (MUR:LON), 0 | Oxford BioMedica plc (OXB:LON), 201 | Primary Health Properties PLC (PHP:LON), 94.0 | R.E.A. Holdings plc (RE:LON), 66.0 | Redx Pharma Plc (REDX:LON), 18.5 | Scancell Holdings Plc (SCLP:LON), 10.2 | Surface Transforms PLC (SCE:LON), 9.2 | 600 Group PLC (SIXH:LON), 2.6 | Tissue Regenix Group plc (TRX:LON), 62.5 | Titon Holdings Plc (TON:LON), 77.5 | Warpaint London PLC (W7L:LON), 412 | ValiRx PLC (VAL:LON), 3.6
- Published:
03 Sep 2018 -
Author:
Hardman & Co Research Team -
Pages:
36
September’s Hardman Monthly features an article from guest contributor, Tim Ward. Tim is the Chief Executive of the Quoted Companies Alliance (QCA), an organisation that champions the interests of small to mid-size quoted companies.